| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $9.1M | +34.4% |
| SG&A Expense | $5.5M | -14.0% |
| Operating Income | -$15.3M | +47.0% |
| Pre-tax Income | -$15.2M | +49.2% |
| Net Income | -$15.2M | +49.2% |
| EPS (Basic) | -$0.39 | +54.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $749K | +34.7% |
| Short-term Investments | $4.1M | -62.9% |
| Current Assets | $5.4M | -57.4% |
| Total Assets | $17.5M | -29.3% |
| Current Liabilities | $2.8M | +166.3% |
| Total Liabilities | $2.8M | +144.0% |
| Stockholders' Equity | $14.7M | -37.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.3M | +37.1% |
| Investing Cash Flow | $6.9M | -65.2% |
| Financing Cash Flow | $5.6M | +7447.7% |